Information
-
Trademark
-
88073859
-
Serial Number
88073859
-
Registration Number
7133412
-
International Classifications
-
Filing Date
August 10, 2018
6 years ago
-
Registration Date
August 08, 2023
a year ago
-
Transaction Date
August 08, 2023
a year ago
-
Status Date
August 08, 2023
a year ago
-
Published for Opposition Date
September 29, 2020
4 years ago
-
Location Date
July 05, 2023
a year ago
-
First Use Anywhere Date
September 27, 2021
3 years ago
-
First Use In Commerce Date
September 27, 2021
3 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
AVENT, TEAGUE A
-
Attorney Docket Number
50125-T89001
Attorney Name
Karen L. Elbing
Law Office Assigned Location Code
N70
-
Owners
Mark Drawing Code
3000
Mark Identification
AB CHECK
Case File Statements
- DM0000: The mark consists of letters "AB" and "CHECK" separated by an array of circles.
- CC0000: Color is not claimed as a feature of the mark.
- D10000: "AB" OR "CHECK"
- GS0421: Scientific and technological services and research projects for the preparation of peptide and antibody libraries, namely, chemical analysis; scientific and technological services and research projects for the identification and characterisation of binding molecules, namely, in the field of antibody discovery, antibody research and antibody optimization in the nature of working on and evaluation of chemical analyses; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, medical research in the field of antibody discovery, antibody research and antibody optimization; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, in the field of antibody discovery, antibody research and antibody optimization, namely, scientific research in the field of antibodies; scientific and technological services and research projects in relation to antibody discovery, namely, medical research in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of natural, engineered and immunized libraries, namely, medical research in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to screening of antibody libraries, namely, in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to phage display, phage panning and yeast display vectors, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection process, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors in the nature of research and development services in the field of antibodies; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic application, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely, in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and non-human lead antibody technology, namely, scientific research in the field of antibody research and antibody optimization
Case File Event Statements
-
8/8/2023 - a year ago
55 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
8/8/2023 - a year ago
54 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
7/6/2023 - a year ago
53 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
7/5/2023 - a year ago
52 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
6/9/2023 - a year ago
51 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/8/2023 - a year ago
50 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
6/8/2023 - a year ago
49 - SOU EXTENSION 5 GRANTED
Type: EX5G
-
5/24/2023 - a year ago
48 - SOU EXTENSION 5 FILED
Type: EXT5
-
5/24/2023 - a year ago
47 - USE AMENDMENT FILED
Type: IUAF
-
5/30/2023 - a year ago
46 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
5/24/2023 - a year ago
45 - TEAS EXTENSION RECEIVED
Type: EEXT
-
5/24/2023 - a year ago
44 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
11/1/2022 - 2 years ago
43 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
10/28/2022 - 2 years ago
42 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
10/28/2022 - 2 years ago
41 - SOU EXTENSION 4 FILED
Type: EXT4
-
10/28/2022 - 2 years ago
40 - TEAS EXTENSION RECEIVED
Type: EEXT
-
5/19/2022 - 2 years ago
39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
5/17/2022 - 2 years ago
38 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
5/17/2022 - 2 years ago
37 - SOU EXTENSION 3 FILED
Type: EXT3
-
5/17/2022 - 2 years ago
36 - TEAS EXTENSION RECEIVED
Type: EEXT
-
10/28/2021 - 3 years ago
35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
10/26/2021 - 3 years ago
34 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
10/26/2021 - 3 years ago
33 - SOU EXTENSION 2 FILED
Type: EXT2
-
10/26/2021 - 3 years ago
32 - TEAS EXTENSION RECEIVED
Type: EEXT
-
4/22/2021 - 3 years ago
31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
4/20/2021 - 3 years ago
30 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
4/20/2021 - 3 years ago
29 - SOU EXTENSION 1 FILED
Type: EXT1
-
4/20/2021 - 3 years ago
28 - TEAS EXTENSION RECEIVED
Type: EEXT
-
11/24/2020 - 4 years ago
27 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
9/29/2020 - 4 years ago
26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
9/29/2020 - 4 years ago
25 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
9/9/2020 - 4 years ago
24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
8/26/2020 - 4 years ago
23 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/25/2020 - 4 years ago
22 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/25/2020 - 4 years ago
21 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/25/2020 - 4 years ago
20 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
4/19/2020 - 4 years ago
19 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
4/19/2020 - 4 years ago
18 - FINAL REFUSAL E-MAILED
Type: GNFR
-
4/19/2020 - 4 years ago
17 - FINAL REFUSAL WRITTEN
Type: CNFR
-
1/16/2020 - 4 years ago
16 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
1/15/2020 - 4 years ago
15 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
1/15/2020 - 4 years ago
14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/17/2019 - 5 years ago
13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
7/17/2019 - 5 years ago
12 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
7/17/2019 - 5 years ago
11 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/13/2019 - 5 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/13/2019 - 5 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/13/2019 - 5 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
1/2/2019 - 6 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
1/2/2019 - 6 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
1/2/2019 - 6 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/28/2018 - 6 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/21/2018 - 6 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
8/18/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
8/14/2018 - 6 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP